About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lupus Clinical Trials in San Antonio | 15 Studies

Clinical Trials LupusSan Antonio

Lupus Clinical Trials in San Antonio

Find 15 clinical trials for lupus near San Antonio, Texas. Connect with research centers in your area.

All Lupus trials nationwide All trials in San Antonio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-15 of 15 trials

RecruitingA Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus ErythematosusThe purpose of this study is to evaluate how well nipocalimab works as compared to placebo in participants with moderate to severe Systemic lupus erythematosus (SLE, a long-term…NCT07438496·Beverly Hills, California and 259 others

Lupus Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedEfficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE)The purpose of this study is to determine if Rozibafusp Alfa could be a useful therapeutic agent in the current treatment landscape where subjects with SLE have ongoing disease…NCT04058028·Birmingham, Alabama and 146 others

TerminatedAscension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint ProsthesisThis study is a non-randomized, consecutive enrollment, one-year post-approval study of patients who are treated with the Ascension® MCP.NCT02408471·Tucson, Arizona and 8 others

Active not recruitingA Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus ErythematosusThis parallel-group, double-blind, placebo-controlled study will evaluate the efficacy and safety of obinutuzumab versus placebo in participants with active, autoantibody-positive…NCT04963296·Anniston, Alabama and 63 others

TerminatedA Study of Ustekinumab in Participants With Active Systemic Lupus ErythematosusThe purpose of this study is to evaluate the efficacy of ustekinumab in participants with active systemic lupus erythematosus (SLE) who have not adequately responded to one or…NCT03517722·Anniston, Alabama and 203 others

Active not recruitingProgram to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus ErythematosusSystemic Lupus Erythematosus (SLE) is an immune-mediated disease associated with inflammation of multiple organ systems.NCT05843643·Chandler, Arizona and 368 others

CompletedSafety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney DiseaseThe purpose of this study is to determine whether LJP 394 (abetimus sodium) is safe and effective in delaying and reducing renal flares in patients with lupus nephritis.NCT00035308·Birmingham, Alabama and 81 others

Active not recruitingA Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus ErythematosusIn this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with systemic lupus erythematosus (SLE).NCT04961567·Birmingham, Alabama and 176 others

TerminatedStudy of LJP 394 in Lupus Patients With History of Renal DiseaseThe primary purpose of this study is to determine whether abetimus sodium is more effective than placebo in delaying time to renal flare in SLE patients with a history of renal…NCT00089804·Birmingham, Alabama and 200 others

TerminatedA Study of Baricitinib (LY3009104) in Participants With Systemic Lupus ErythematosusThe reason for this study is to see how effective and safe the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE).NCT03616912·Birmingham, Alabama and 183 others

CompletedActhar Gel for Active Systemic Lupus Erythematosus (SLE)This trial is to study Acthar Gel in participants with active systemic lupus erythematosus (SLE).NCT02953821·Hemet, California and 38 others

CompletedStudy of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of CareThis study will be conducted to assess the safety, tolerability, and immunogenicity of repeat doses of BOS161721 (20 milligrams \[mg\], 60 mg, and 120 mg) administered…NCT03371251·Anniston, Alabama and 67 others

CompletedMyofascial Techniques and Proprioceptive Neuromuscular Facilitation in Patients With Systemic Lupus Erythematosus.Introduction. Systemic lupus erythematosus is an autoimmune disease.NCT06383104·Murcia

TerminatedEfficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus ErythematosusThe primary objective is to evaluate the efficacy and safety of efavaleukin alfa in subjects with active systemic lupus erythematosus.NCT04680637·Birmingham, Alabama and 149 others

CompletedA Study of Belimumab in Subjects With Systemic Lupus ErythematosusThe purpose of this study is to evaluate the efficacy, safety, tolerability, and impact on quality of life of two different doses of belimumab administered in addition to standard…NCT00410384·Birmingham, Alabama and 145 others

Other Conditions in San Antonio

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia